Perspective Therapeutics, Inc. - 10-Q Filing

Perspective Therapeutics, Inc. reports Q3 financial results including research and development expense trends and fair value disclosures for various debt securities.

SEC EDGAR ·

Tickers: $CATX

Read the full article at SEC EDGAR

More Regulatory news